GHI
ABBV icon

Gross & Hartman Investments’s AbbVie ABBV Stock Holding History

Gross & Hartman Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Sell
888
-135
-13% -$29K 0.1% 72
2026
Q1 		$222K Sell
1,023
-153
-13% -$33.9K 0.12% 67
2025
Q4 		$269K Buy
+1,176
New +$268K 0.15% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Gross & Hartman Investments's ABBV Position: Q2 2026 in Review

Gross & Hartman Investments reduced its AbbVie (ABBV) stake by 13% in Q2 2026, selling an estimated $29K and leaving 888 shares worth $223K. The position accounts for 0.1% of the portfolio, ranked #72.

Gross & Hartman Investments first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $269K in Q4 2025. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Gross & Hartman Investments held 888 shares of AbbVie worth $223K as of Q2 2026.
  • Gross & Hartman Investments sold 135 AbbVie shares in Q2 2026, an estimated $29K.
  • AbbVie made up 0.1% of Gross & Hartman Investments's portfolio in Q2 2026, its #72 holding.
  • Gross & Hartman Investments first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Gross & Hartman Investments's AbbVie position peaked at $269K in Q4 2025.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gross & Hartman Investments's 13F filing for Q2 2026, filed 13 Aug 2026.